title: Hot topics in the prevention of respiratory syncytial virus disease.
abstract: The 7th International Respiratory Syncytial Virus Symposium took place in Hotel Blijdorp, Rotterdam, The Netherlands. The series has been running since 1996; this meeting took place after a 3-year gap, and was attended by approximately 200 clinicians, scientists and industry representatives from all over the world. The conference covered all aspects of respiratory syncytial virus disease, including virology, cell biology, pathogenesis, clinical presentation, diagnosis, immunology, vaccines, antivirals and other therapeutic approaches. Reviews by invited keynote speakers were accompanied by oral and poster presentations, with ample opportunity for discussion of unpublished work. This article summarizes a small selection of hot topics from the meeting, focused on pathogenesis, therapeutics and vaccine development.
authors: Centre for Respiratory Infection/MRC and Asthma UK Centre, Faculty of Medicine, Imperial College London, London, W2 1PG, UK.
authors: Maximillian S
authors: MS
authors: Habibi
authors: Sanjay
authors: S
authors: Patel
authors: Peter
authors: P
authors: Openshaw
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control* / Q000821:virology; D022261:Respiratory Syncytial Virus Vaccines / Q000276:immunology*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology / Q000472:pathogenicity*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D022261:Respiratory Syncytial Virus Vaccines